Annemieke
Aartsma
Ph.D., Leiden University Medical Center
Amelia
Adams
Denali Therapeutics
Allyson
Berent
Ph.D., Angelman Syndrome
Tom
Brown
Ph.D., University of Oxford
Thomas R.
Cech
Ph.D. *Keynote Speaker
Vikash P.
Chauchan
Ph.D. Massachusetts Institute of Technology
Brendon E.
Cook
Ph.D., Biogen
Hagen
Cramer
Ph.D., QurAlis
Craig
Duvall
Ph.D., Cornelius Vanderbilt University
Martin
Egli
Ph.D., Vanderbilt University
Justin
Eyquem
Ph.D., University of California, San Francisco
Hassan H.
Fakih
Ph.D., UMass Chan Medical School
Kevin
Fettes
Ph.D., FTS Pharma Consulting
Stephanie
Fradette
Ph. D., Biogen
Malgorzata
Gonciarz
Ph.D., Novartis
James
Gorman
Ph.D., Wyss Institute at Harvard
Lianxiu
Guan
Ph.D., AmGen
Peter
Hagedorn
Ph.D., Contera Pharma
Meena
Indrakanti
Ph.D., Stoke Therapeutics
Yousuke
Katsuda
Ph.D., Kumamoto University
Sarita
Kattel
Ph.D., US Pharmacopeia
Art
Levin
Ph.D., Avidity Biosciences
Xiaocen (Chris)
Li
Ph.D., Hongene
Madder
Ph.D., Ghent University
Prashant
Mali
Ph.D., UCSD
Natalia
Martin-Orozco
Ph.D., Providence Therapeutics
Maureen
McKeague
Ph.D., McGill University
Eduardo
Paredes
Ph.D., Leal Therapeutics
Laura
Sepp-Lorenzino
Ph.D., GNMmeds LLC
René
Thürmer
Ph.D., BfArM
Paula
Trefiak
Saskatchewan Workers' Compensation Board
Jing
Yang
Ph.D., BaseCure Therapeutics
Gene
Yeo